Partner Headlines - ICPT

  1. Benzinga's Top Initiations

    Benzinga
  2. Cowen Initiates Intercept At Outperform

    Benzinga
  3. Four biotech takeover targets?

    IBD
  4. 4 Biotechs That Might Be Bought Soon

    IBD
  5. InterMune Stock Spikes On Rare Big Biotech Buyout

    IBD
  6. Morning Market Losers

    Benzinga
  7. Benzinga's Top #PreMarket Losers

    Benzinga
  8. CNBC's Stock Pops & Drops From August 12

    Benzinga
  9. Markets Marginally Lower In Quiet Trading Session

    Benzinga
  10. U.S. Job Openings Climb; Leerink Swann Bullish On Intercept Pharmaceuticals

    Benzinga
  11. U.S. Stocks Fall; Dealertrack Shares Surge On Upbeat Results

    Benzinga
  12. Markets Mostly Flat; Flowers Foods Profit Misses Estimates

    Benzinga
  13. Stocks Stake Out Thin Gains; Intercept, Insys, Autohome Gain

    IBD
  14. Intercept Pharma Soars On Liver-Disease Drug Data

    IBD
  15. Benzinga's Volume Movers

    Benzinga
  16. Morning Market Movers

    Benzinga
  17. Conatus Shares Move Higher On Industry Data

    Benzinga
  18. Stock Futures Hem And Haw; Intercept Pharmaceuticals Soars

    IBD
  19. Benzinga's Top #PreMarket Gainers

    Benzinga
  20. Intercept Pharma Soars On Positive Liver Drug Data

    IBD
  21. INTERCEPT PHARMACEUTICALS

    IBD
  22. Intercept Pharmaceutical's Shares Soar On Earnings

    Benzinga
  23. Steven Cohen Has a Track Record of Impressive Returns

    GuruFocus
  24. Intercept Pharmaceutical Shares Up Amid Deutsche Bank Initiation

    Benzinga
  25. Markets Little Changed Ahead Of 4th Of July Break

    Benzinga
  26. Benzinga's Top Initiations

    Benzinga
  27. Analysts Comment On Intercept Amid Share Decline Following FLINT ...

    Benzinga
  28. Top Healthcare Movers For June 9, 2014

    Benzinga
  29. Market Wrap For April 14: Markets Surge on Positive Retail Data, ...

    Benzinga
  30. Weekly CFO Sells Highlight: Intercept Pharmaceuticals Inc., ...

    GuruFocus
  31. Intercept Issues Preclinical Data Showing OCA's Potential Role ...

    Benzinga
  32. US Stock Futures Nudge Higher Ahead Of Jobs Data

    Benzinga
  33. Market Wrap For March 17: Investors Focused On Economic Data ...

    Benzinga
  34. Intercept Pharmaceuticals Announces Q4 Earnings

    Benzinga
  35. Stocks Near Session Highs; Kandi Up 26% On Q4 Results

    IBD
  36. Top Trending Tickers On StockTwits For March 17

    Benzinga
  37. Benzinga's Top #PreMarket Losers

    Benzinga
  38. Morning Gainers for Friday, March 14, 2014

    Benzinga
  39. Biotech ETFs Flash Buy Signals (XBI, IBB, BBH, ICPT)

    Benzinga
  40. Shares of Intercept Pharma Rise as BofA Sees US, EU Regulators ...

    Benzinga
  41. Fatty Liver Disease Should Keep Stocks Moving In 2014

    IBD
  42. Precious Metals, Health Care Led Mutual Funds In Feb.

    IBD
  43. Which Sector Produced 8 Of The 10 Top Percentage Gainers In 2 ...

    Benzinga
  44. Mid-Morning Market Update: Markets Rise; Bank of America Profit ...

    Benzinga
  45. Benzinga's Top #PreMarket Gainers

    Benzinga
  46. Market Wrap For January 14: Markets Rebound On Earnings Season ...

    Benzinga
  47. Mid-Afternoon Market Update: Markets Continue Rally as Tesla ...

    Benzinga
  48. Stocks Up In Afternoon; Tesla Soars On Strong Sales

    IBD
  49. Biotech Stocks Back On Top, Led By Biogen, Alexion

    IBD
  50. Morning Market Losers

    Benzinga
  51. Benzinga's Top #PreMarket Losers

    Benzinga
  52. Intercept Reports Additional Details About FLINT Clinical Trial ...

    Benzinga
  53. Intercept to Present at the JP Morgan Healthcare Conference on ...

    Benzinga
  54. Market Wrap For January 10: Job Growth Weak, But Unemployment ...

    Benzinga
  55. Mid-Afternoon Market Update: Plug Rises on Secondary Pricing ...

    Benzinga
  56. Mid-Day Market Update: Abercrombie & Fitch Surges On Strong Outlook; ...

    Benzinga
  57. Intercept Shares Skyrocket 500% This Week

    FoxBusiness
  58. Mid-Morning Market Update: Markets Drop; Alcoa Q4 Earnings Miss ...

    Benzinga
  59. Bank of America Reiterates on Intercept Pharmaceuticals

    Benzinga
  60. Benzinga's Volume Movers

    Benzinga
  61. Stocks Hitting 52-Week Highs

    Benzinga
  62. Citi Maintains on Intercept Pharmaceuticals

    Benzinga
  63. Stock Futures Trim Early Gains; Oriental Education Leads IBD ...

    IBD
  64. Benzinga's Top #PreMarket Gainers

    Benzinga
  65. Intercept drug hits endpoint

    IBD
  66. Mid-Afternoon Market Update: Markets Moving Sideways Ahead of ...

    Benzinga
  67. Mid-Day Market Update: U.S. Stocks Turn Red; Bed Bath & Beyond ...

    Benzinga
  68. Intercept Pharma Liver-Disease Drug Scores In Trial

    IBD
  69. Benzinga's Volume Movers

    Benzinga
  70. Morning Market Movers

    Benzinga
  71. Benzinga's Top #PreMarket Gainers

    Benzinga
  72. Intercept Pharmaceutical Shares Skyrocket after Oppenheimer's ...

    Benzinga
  73. Intercept Prices 1.5M Share Offering at $62.50/Share

    Benzinga
  74. UPDATE: BMO Capital Markets Raises PT on Intercept Pharmaceuticals ...

    Benzinga
  75. UPDATE: Wedbush Raises PT on Intercept Pharmaceuticals Following ...

    Benzinga
  76. Intercept Pharma Begins Phase 2 NASH Trial of OCA in Japan

    Benzinga
  77. Intercept Pharmaceuticals Completes Enrollment in Phase 3 Primary ...

    Benzinga
  78. UPDATE: BMO Capital Markets Initiates Intercept Pharmaceuticals ...

    Benzinga
  79. Stocks Hitting 52-Week Lows

    Benzinga
  80. Four IPOs Burst Out The Gate

    IBD
  81. Realogy, Shutterstock IPOs, More New Stocks Take Off

    IBD
  82. Realogy, Shutterstock IPOs, More New Stocks Take Off

    IBD
Trading Center